Loading organizations...
Key people at DCP Capital.
DCP Capital was founded in 2017 by Julian Wolhardt (Co-Founder, Chief Executive Officer and member of the Investment Committee) and David Liu (Co-Founder, Executive Chairman and member of the Investment Committee).
DCP Capital operates as an international private equity firm, focusing its investments across Asia's consumer, healthcare, education, and technology sectors. It employs a disciplined, operationally focused strategy, leveraging global experience and local networks. This approach helps identify and cultivate opportunities, applying deep industry knowledge and robust operational capabilities to its portfolio.
Founded in 2017 by David Liu and Julian Wolhardt, DCP Capital emerged from their leadership at KKR and Morgan Stanley's Asian private equity divisions. Their insight created an investment platform for the Chinese market, focusing on buyouts, state-owned enterprise reforms, and strategic cross-border deals that capitalize on local dynamics.
DCP Capital partners with a global base of institutional investors, including sovereign wealth funds and pension funds. Its vision centers on fostering enduring, mutually beneficial relationships with portfolio companies, actively contributing to strategic growth. The firm aims to maximize sustainable value creation through focused support and initiatives across its chosen industries.
DCP Capital was founded in 2017 by Julian Wolhardt (Co-Founder, Chief Executive Officer and member of the Investment Committee) and David Liu (Co-Founder, Executive Chairman and member of the Investment Committee).
DCP Capital has 2 tracked investments across 2 companies. The latest tracked deal is $2.2B Series G in Yuanfudao in October 2020.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Oct 26, 2020 | Yuanfudao | $2.2B Series G | DST Global, Tencent Holdings | Boyu Capital, CPE, Danhe Capital, GIC, Greenwoods, Hillhouse Capital, IDG Capital, Ocean Link, TBP, Temasek |
| Oct 8, 2013 | Amaranth Medical | $20.0M Series B | DCP Capital | Swee Yeok Chu, PBM, Fred M. Schwarzer, Phillip Capital, Venstar Capital |
Key people at DCP Capital.
